GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (STU:SH0) » Definitions » Capital Expenditure

Shionogi (STU:SH0) Capital Expenditure : €-329.27 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Shionogi Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Shionogi's cash flow for capital expenditures for the three months ended in Sep. 2024 was €-39 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2024 was €-329.27 Mil.

Shionogi Capital Expenditure Historical Data

The historical data trend for Shionogi's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shionogi Capital Expenditure Chart

Shionogi Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -98.92 -254.58 -241.70 -259.85 -173.58

Shionogi Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36.01 -59.07 -42.93 -188.43 -38.84

Shionogi Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-329.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shionogi Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (STU:SH0) » Definitions » Capital Expenditure
Comparable Companies
TSE:4523 TSE:4581 TSE:4516 TSE:4530 TSE:4887 TSE:4540 TSE:4506 TSE:4547 TSE:4521 TSE:4534 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA XSWX:SDZ VTRS NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
SGIOY:USA SGIOF:USA 4507:Japan SH0:Germany
Address
1-8, Doshomachi 3-chome, Chuo-ku, Osaka, JPN, 541-0045
Website
http://www.shionogi.co.jp
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.

Shionogi Headlines

No Headlines